Status:

COMPLETED

Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

Lead Sponsor:

AB Biotics, SA

Collaborating Sponsors:

Innovacion y Desarrollo de Estrategias en Salud

Hospital General Dr. Manuel Gea González

Conditions:

SARS-CoV Infection

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

Clinical research focused to evaluate the effect as coadyuvant of a combination of L. plantarum and P. acidilactici in adults positive for SARS-CoV-2 with mild clinical COVID-19 symptoms. Main objecti...

Detailed Description

Randomized controlled trial (RCT) to evaluate safety and efficacy of Lactobacillus plantarum CECT 30292, Lactobacillus plantarum CECT 7484, Lactobacillus plantarum CECT 7485 y P. acidilactici CECT 748...

Eligibility Criteria

Inclusion

  • Women or men, \>18y to 60 years
  • RTq-PCR to COVID positive
  • Presence of cough, fever, dyspnoea, or headache, onset \<= 7 days
  • Mild severity of COVID-19
  • Peripheral Oxygen Saturation (SpO2) \>90%
  • Able to read, understand and sign the informed consent
  • To have at least one family member to collaborate with the follow-up in the clinical findings at beginning and throughout of the study.

Exclusion

  • Severe Obesity (BMI\>40)
  • Uncontrolled Type II diabetes (HbA1C \>8.0)
  • Uncontrolled systolic hypertension (\>160mmdeHg)
  • Acute pancreatitis
  • Chronic diarrhea or constipation
  • Inflammatory bowel disease
  • Blood clotting disease
  • Immunosuppression derived from Cancer, post-transplantation, auto-immune disease or HIV
  • Severe and active seasonal allergies
  • Pregnancy or lactation
  • Glucose 6P-dehydrogenase deficiency
  • Regular use of probiotic or antibiotic within 2 weeks before entering the trial
  • Severe or uncontrolled Chronic Respiratory Diseases (Asthma, COPD or Cystic Fibrosis)

Key Trial Info

Start Date :

August 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 2 2021

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04517422

Start Date

August 19 2020

End Date

February 2 2021

Last Update

May 6 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital General Dr. Manuel Gea Gonzalez

Mexico City, Mexico, 14080